Abstract
Purpose: Primary carnitine deficiency is an autosomal recessive disorder caused by defective carnitine transport and manifests as nonketotic hypoglycemia or skeletal or heart myopathy.
Methods: To define the mechanisms producing partially reduced plasma carnitine levels in the parents of affected patients, we examined carnitine transport in vivo and in the fibroblasts of a new patient and his heterozygous parents.
Results: Kinetic analysis of carnitine transport in fibroblasts revealed an absence of saturable carnitine transport in the proband's cells and a partially impaired carnitine transport in fibroblasts from both parents, whose cells retained normal Km values toward carnitine (6–9 μM) but reduced Vmax. At steady state, normal fibroblasts accumulated carnitine to a concentration that was up to 80 times the extracellular value (0.5 μM). By contrast, cells from the proband had minimal carnitine accumulation, and cells from both parents had intermediate values of carnitine accumulation. Plasma carnitine levels were slightly below normal in both heterozygous, yet clinically normal, parents and in the paternal grandfather and the maternal grandmother. To define the mechanism producing partially decreased carnitine levels, we studied urinary carnitine losses in heterozygous parents compared with controls. Urinary losses increased linearly (P < 0.05) with plasma carnitine levels in normal controls. When urinary carnitine losses were normalized to plasma carnitine levels, a significant difference was observed between controls and heterozygous individuals (P < 0.01).
Conclusions: These results indicate that fibroblasts from heterozygotes for primary carnitine deficiency have a decreased capacity to accumulate carnitine and that heterozygotes have increased urinary losses, which may contribute to their reduced plasma carnitine levels.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Scaglia, F., Wang, Y., Singh, R. et al. Defective urinary carnitine transport in heterozygotes for primary carnitine deficiency. Genet Med 1, 34–39 (1998). https://doi.org/10.1097/00125817-199811000-00008
Issue Date:
DOI: https://doi.org/10.1097/00125817-199811000-00008
Keywords
This article is cited by
-
Exome sequencing identifies primary carnitine deficiency in a family with cardiomyopathy and sudden death
European Journal of Human Genetics (2017)
-
A Moderate Carnitine Deficiency Exacerbates Isoproterenol-Induced Myocardial Injury in Rats
Cardiovascular Drugs and Therapy (2016)
-
Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe Islands
Journal of Inherited Metabolic Disease (2014)
-
Primary Carnitine deficiency in the Faroe Islands: health and cardiac status in 76 adult patients diagnosed by screening
Journal of Inherited Metabolic Disease (2014)
-
Primary carnitine deficiency and pivalic acid exposure causing encephalopathy and fatal cardiac events
Journal of Inherited Metabolic Disease (2013)